Broadcast
    Markets

    Finland's IQM to become one of Europe's first listed quantum companies at $1.8 billion valuation

    CNBCFebruary 23, 2026 at 12:07 PMBullish1 min read

    Key Takeaways

    • 1IQM is seeking a public listing at a valuation of $1.8 billion, positioning it as a leading hardware player in the European quantum ecosystem.
    • 2The company employs a full-stack strategy, controlling the manufacturing of superconducting quantum processing units (QPUs) which provides a competitive edge in supply chain reliability.
    • 3The listing comes at a pivotal time when sovereign independence in high-performance computing is becoming a primary strategic goal for the European Union.
    • 4IQM’s revenue model is transitioning from scientific research sales to 'Quantum-as-a-Service' models and on-premise deployments for high-security government and corporate clients.

    IQM Quantum Computers' move toward a public listing marks a watershed moment for the European deep-tech sector, representing one of the continent's first pure-play quantum computing IPOs at a rigorous $1.8 billion valuation. This development highlights a shift in investor appetite toward infrastructure-heavy artificial intelligence and next-generation computing, as traditional silicon-based architectures approach physical scaling limits. IQM differentiates itself through a 'full-stack' approach—manufacturing its own superconducting processors and assembling complete quantum systems—which positions it as a direct competitor to US giants like IBM and Google, as well as specialized firms like IonQ and Rigetti. This listing serves as a crucial test for the European capital markets' ability to fund capital-intensive hardware ventures that typically migrate to US exchanges for higher liquidity. Investors should view this as a gauge of the 'Quantum Winter's' end; a successful debut could catalyze a wave of European tech listings. Moving forward, the key metric for IQM will be its transition from research-led government contracts to commercial enterprise partnerships, particularly in the pharmaceutical and financial modeling sectors where quantum advantage is most imminent.

    Related Articles